- Abstract:
-
BACKGROUND: Zidovudine (AZT) monotherapy was the first antiretroviral drug to be tested widely. Subsequent trials in asymptomatic or early symptomatic HIV infection indicated short-term delays in disease progression with AZT, but not improved survival. OBJECTIVES: To assess the effects of immediate versus deferred zidovudine (AZT) on HIV disease progression and survival. SEARCH STRATEGY: Investigators and pharmaceutical companies were contacted, and MEDLINE searches were supplemented by sear...
Expand abstract - Journal:
- The Cochrane database of systematic reviews
- Issue:
- 3
- Pages:
- CD002039
- Publication date:
- 2000
- DOI:
- EISSN:
-
1469-493X
- ISSN:
-
1469-493X
- URN:
-
uuid:27aa5830-d5fa-4aea-b5be-ff0f4ad16a0f
- Source identifiers:
-
196435
- Local pid:
- pubs:196435
- Language:
- English
- Keywords:
- Copyright date:
- 2000
Journal article
Immediate versus deferred zidovudine (AZT) in asymptomatic or mildly symptomatic HIV infected adults.
Actions
Authors
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record